NMGX 10-Q Quarter ended Sept. 30, 2023

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

☒ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2023

☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

COMMISSION FILE NO. 1-11602

NANO MAGIC INC.

(Exact name of registrant as specified in its charter)

Delaware		47-1598792
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

31601 Research Park Drive , Madison Heights , MI 48071

(Address of principal executive office, including Zip Code)

Registrant’s telephone number, including area code: (844) 273-6462

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class		Trading Symbol		Name of Each Exchange on Which Registered
Common Stock, $0.0001 par value		NMGX		OTC Markets

Securities registered pursuant to Section 12(g) of the Exchange Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☐ Yes ☒ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “accelerated filer”, “large accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)	Smaller reporting company ☒
Emerging growth company ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No .

As of November 14, 2023, the registrant had 12,352,316 shares of Common Stock issued and outstanding.

Nano Magic Inc.

INDEX

		Page
Part I. Financial Information
Item 1. Financial Statements (Unaudited)		F-1
Condensed Consolidated Statements of Operations—Three and Nine Months Ended September 30, 2023 and 2022		F-1
Condensed Consolidated Balance Sheets—September 30, 2023 and December 31, 2022		F-2
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended September 30, 2023 and 2022		F-3
Consolidated Statements of Changes in Stockholders’ Equity for the Nine Months Ended September 30, 2023 and 2022 (unaudited)		F-4
Condensed Consolidated Statements of Cash Flows—Nine Months Ended September 30, 2023 and 2022		F-5
Notes to Unaudited Condensed Consolidated Financial Statements		F-6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		4
Item 3. Quantitative and Qualitative Disclosures about Market Risk		7
Item 4. Controls and Procedures		7
Part II. Other Information
Item 1. Legal Proceedings		8
Item 1A. Risk Factors		8
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		8
Item 3. Defaults Upon Senior Securities		8
Item 4. Mine Safety Disclosures		8
Item 5. Other Information		8
Item 6. Exhibits		9
Signatures		10

FORWARD-LOOKING STATEMENTS

This Form 10-Q contains certain forward-looking statements that we believe are within the meaning of the federal securities laws. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements, including the statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our strategy, future operations, future expectations or future estimates, financial position and objectives of management. Those statements in this Form 10-Q containing the words “believes,” “anticipates,” “plans,” “expects” and similar expressions constitute forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on our current expectations and are subject to a number of risks, uncertainties and assumptions relating to our operations, results of operations, competitive factors, shifts in market demand and other risks and uncertainties.

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate and actual results may differ from those indicated by the forward-looking statements included in this Form 10-Q. In light of the significant uncertainties inherent in the forward-looking statements included in this Form 10-Q, you should not consider the inclusion of such information as a representation by us or anyone else that we will achieve such results. Moreover, we assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements.

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

		2023				2022				2023				2022
		For the Three Months Ended								For the Nine Months Ended
		September 30,								September 30,
		2023				2022				2023				2022
NET REVENUES		$	658,159			$	807,026			$	2,064,481			$	1,819,951
COST OF SALES			575,680				698,448				1,705,114				1,689,342
GROSS PROFIT			82,479				108,578				359,367				130,609
OTHER OPERATING INCOME			-				95,701				11,420				95,701
OPERATING EXPENSES:
Selling and marketing expenses			69,242				88,635				182,684				264,465
Salaries, wages and related benefits			233,701				308,745				702,263				1,021,463
Stock compensation expense			119,999				50,528				410,392				157,149
Research and development			24,375				4,566				36,650				15,266
Professional fees			78,080				129,362				380,301				572,135
General and administrative expenses			220,230				183,728				667,744				646,989
Total Operating Expense			745,627				765,564				2,380,034				2,677,467
LOSS FROM OPERATIONS			( 663,148	)			( 561,285	)			( 2,009,247	)			( 2,451,157	)
OTHER INCOME (EXPENSE)
Income (loss) from investment in subsidiary			( 21,267	)			19,203				19,671				16,042
Interest expense			( 12,068	)			( 10,779	)			( 34,011	)			( 26,414	)
Other income (expense)			( 3,192	)			10,267				20,010				12,892
Total Other Income (Expense)			( 36,527	)			18,691				5,670				2,520
LOSS FROM CONTINUING OPERATIONS			( 699,675	)			( 542,594	)			( 2,003,577	)			( 2,448,637	)
INCOME FROM DISCONTINUED OPERATIONS
Income from discontinued operations			-				-				-				1,300
Gain on sale of discontinued operations			-				-				-				1,148,225
NET INCOME FROM DISCONTINUED OPERATIONS			-				-				-				1,149,525
NET LOSS		$	( 699,675	)		$	( 542,594	)		$	( 2,003,577	)		$	( 1,299,112	)
NET LOSS PER SHARE - BASIC:
Continuing operations		$	( 0.06	)		$	( 0.05	)		$	( 0.18	)		$	( 0.24	)
Discontinued operations		$	-			$	-			$	-			$	0.11
NET LOSS PER SHARE - BASIC:		$	( 0.06	)		$	( 0.05	)		$	( 0.18	)		$	( 0.13	)
NET INCOME (LOSS) PER SHARE - DILUTED:
Continuing operations		$	( 0.06	)		$	( 0.05	)		$	( 0.18	)		$	( 0.24	)
Discontinued operations		$	-			$	-			$	-			$	0.11
NET LOSS PER SHARE - DILUTED:		$	( 0.06	)		$	( 0.05	)		$	( 0.18	)		$	( 0.13	)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic			11,293,388				10,108,489				11,105,186				10,184,881
Diluted			11,293,388				10,108,489				11,105,186				10,184,881

See accompanying notes to condensed consolidated financial statements.

NANO MAGIC INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

		September 30				December 31
		2023				2022
ASSETS
CURRENT ASSETS:
Cash		$	123,173			$	259,223
Accounts receivable, net			321,580				348,565
Inventory, net			992,717				1,120,073
Prepaid expenses			89,647				132,997
Current portion of note receivable			45,000				40,000
Total Current Assets			1,572,117				1,900,858
Operating lease right-of-use assets			878,414				1,037,749
Property, plant and equipment, net			451,029				525,809
Note receivable, non-current			326,175				375,983
Non-marketable equity investment in subsidiary			269,818				250,146
Total Assets		$	3,497,553			$	4,090,545
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable		$	741,603			$	762,524
Accounts payable - related parties			92,958				87,119
Accounts payable			92,958				87,119
Accrued expenses and other current liabilities			431,055				276,132
Current portion of notes payable			50,000				26,629
Current portion of finance leases			23,603				39,005
Advances from related parties			42,887				42,887
Current portion of operating lease liabilities			158,504				142,173
Total Current Liabilities			1,540,610				1,376,469
Notes Payable, net of current portion			420,716				350,000
Finance leases, net of current portion			6,274				24,194
Operating lease liabilities, net of current portion			589,344				722,420
Total Liabilities			2,556,944				2,473,083
Commitments and Contingencies (See Note 9)			-				-
STOCKHOLDERS’ EQUITY:
Preferred stock, $ 0.0001 par value, 100,000 shares authorized; no shares issued and outstanding			-				-
Common stock: $ 0.0001 par value, 30,000,000 shares authorized; 11,966,146 and 10,722,431 issued and outstanding at September 30, 2023 and December 31, 2022, respectively			1,196				1,072
Additional paid-in capital			15,089,743				13,763,143
Accumulated deficit			( 14,150,330	)			( 12,146,753	)
Total Stockholders’ Equity			940,609				1,617,462
Total Liabilities and Stockholders’ Equity		$	3,497,553			$	4,090,545

See accompanying notes to consolidated financial statements.

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

(unaudited)

		Shares				Amount				Capital				Deficit				Equity
		Class A Common Stock								Additional Paid-in				Accumulated				Total Stockholders’
		Shares				Amount				Capital				Deficit				Equity
Balance, June 30, 2023			11,180,953			$	1,117			$	14,569,823			$	( 13,450,655	)			1,120,285
Common stock issued for cash, net of issuance costs			669,813				67				403,869				-				403,936
Stock-based compensation			-				-				57,601				-				57,601
Restricted stock issued for services			115,380				12				62,386				-				62,398
Warrants and options on private placement			-				-				( 3,936	)			-				( 3,936	)
Net loss			-				-				-				( 699,675	)			( 699,675	)
Balance, September 30, 2023			11,966,146				1,196				15,089,743				( 14,150,330	)			940,609
Balance, June 30, 2022			10,361,015			$	1,036			$	13,251,565			$	( 10,801,682	)			2,450,919
Common stock issued for cash, net of issuance costs			69,445				7				121,522				-				121,529
Stock-based compensation			-				-				50,528				-				50,528
Warrants and options on private placement			-				-				3,471				-				3,471
Net loss			-				-				-				( 542,594	)			( 542,594	)
Balance, September 30, 2022			10,430,460				1,043				13,427,086				( 11,344,276	)			2,083,853

See accompanying notes to condensed consolidated financial statements.

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

(unaudited)

		Class A Common Stock								Additional Paid-in				Accumulated				Stockholders’
		Shares				Amount				Capital				Deficit				Equity
Balance, December 31, 2022			10,722,431			$	1,072			$	13,763,143			$	( 12,146,753	)			1,617,462
Common stock issued for cash, net of issuance costs			998,613				99				843,408				-				843,507
Stock-based compensation			-				-				343,276				-				343,276
Stock issued for services			52,800				5				65,995				-				66,000
Restricted stock issued for services			192,302				20				67,096				-				67,116
Warrants and options on private placement			-				-				6,825				-				6,825
Net loss			-				-				-				( 2,003,577	)			( 2,003,577	)
Balance, September 30, 2023			11,966,146				1,196				15,089,743				( 14,150,330	)			940,609
Balance, December 31, 2021			9,702,680			$	970			$	11,960,011			$	( 10,045,164	)			1,915,817
Balance			9,702,680			$	970			$	11,960,011			$	( 10,045,164	)			1,915,817
Common stock issued for cash, net of issuance costs			727,780				73				1,273,542				-				1,273,615
Stock-based compensation			-				-				157,149				-				157,149
Warrants and options on private placement			-				-				36,384				-				36,384
Net loss			-				-				-				( 1,299,112	)			( 1,299,112	)
Balance, September 30, 2022			10,430,460				1,043				13,427,086				( 11,344,276	)			2,083,853
Balance			10,430,460				1,043				13,427,086				( 11,344,276	)			2,083,853

See accompanying notes to condensed consolidated financial statements.

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

		2023				2022
		For the Nine Months Ended
		September 30,
		2023				2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss from continuing operations		$	( 2,003,577	)		$	( 2,448,637	)
Net income from discontinued operations			-				1,149,525
Adjustments to reconcile net loss to net cash provided by operating activities:
Change in inventory obsolescence reserve			75,841				( 2,888	)
Depreciation and amortization expense			84,132				84,222
Bad debt expense			80,896				17,980
Stock-based compensation			476,392				157,149
Income from investment in subsidiary			( 19,671	)			( 16,042	)
Change in operating assets and liabilities:
Accounts receivable			( 53,911	)			( 80,900	)
Inventory			51,515				57,265
Prepaid expenses and contract assets			43,350				44,249
Accounts payable			3,887				371,805
Accounts payable - related party			5,839				( 6,065	)
Operating lease liabilities			42,590				44,361
Accrued expenses			154,923				128,995
Contract liabilities			-				159,688
Total adjustments			945,783				959,819
Net cash used by continuing operating activities			( 1,057,794	)			( 1,488,818	)
Net cash used by discontinued operating activities			-				( 72,245	)
NET CASH USED BY OPERATING ACTIVITIES			( 1,057,794	)			( 1,561,063	)
CASH FLOWS FROM CONTINUING INVESTING ACTIVITIES
Proceeds from note receivable			20,000				25,000
Purchases of property and equipment			( 9,352	)			( 4,910	)
NET CASH PROVIDED BY INVESTING ACTIVITIES			10,648				20,090
CASH FLOWS FROM CONTINUING FINANCING ACTIVITIES
Proceeds from sale of common stock and warrants			850,332				1,310,000
Proceeds from issuance of convertible debt, net of discount			94,467				300,000
Repayment of bank loans			( 1,630	)			( 25,392	)
Repayment of finance leases			( 32,073	)			( 33,758	)
Repayment of advances from related parties			-				( 66,065	)
Net cash provided by continuing financing activities			911,096				1,484,785
Net cash provided by discontinued financing activities			-				20,000
NET CASH PROVIDED BY FINANCING ACTIVITIES			911,096				1,504,785
NET DECREASE IN CASH			( 136,050	)			( 36,188	)
CASH in continuing operations, beginning of year			259,223				197,932
CASH in discontinued operations, beginning of year			-				44,542
CASH, end of period		$	123,173			$	206,286
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest		$	23,973			$	26,995

See accompanying notes to condensed consolidated financial statements.

NANO MAGIC INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2023

(unaudited)

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

Organization

Nano Magic Inc. (“we”, “us”, “our”, “Nano Magic” or the “Company”), a Delaware corporation, develops and sells a portfolio of nano-layer coatings, nano-based cleaners, and nano-composite products based on its proprietary technology. On March 2, 2021 we changed our name to Nano Magic Holdings Inc. On December 31, 2022, our wholly-owned subsidiary Nano Magic LLC was merged into the parent company and we changed our name to Nano Magic Inc.

Effective May 31, 2022, we sold a 70 % interest in our subsidiary, Applied Nanotech, Inc. (“ANI”). The contract research services performed by ANI for governmental and private customers was previously reported as our Contract research segment. As a result of this sale, the Company has deconsolidated ANI from its financial reporting, and we now report as only one segment. We retain a 30 % interest in ANI that is now recorded as an equity investment.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information. Accordingly, they do not include all the information and disclosures required by US GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of September 30, 2023 and for the three and nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. The balance sheet at December 31, 2022 has been derived from the audited financial statement at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures of the Company as of December 31, 2022 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 11, 2023.

Going Concern

These unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the unaudited consolidated financial statements, the Company had losses from continuing operations and net cash used by continuing operations of $ 2,003,577 and $ 1,057,794 for the nine months ended September 30, 2023 and a loss from continuing operations of $ 2,448,637 and cash used by continuing operations $ 1,488,818 for the nine months ended September 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited consolidated financial statements are issued. Management cannot provide assurance that the Company will ultimately achieve profitable operations, become cash flow positive or raise additional capital. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. They do not include any adjustments related to the recoverability and/or classification of the recorded asset amounts and/or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Reclassifications

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period. These reclassifications had no effect on the previously reported net loss.

F- 6

NOTE 2 – DISCONTINUED OPERATIONS

Effective May 31, 2022, we sold a 70 % interest in our subsidiary ANI to two of its officers and long-term employees in exchange for a promissory note in the face amount of $ 450,000 . The note bears interest at 7 % and has semi-annual payments of principal initially in the amount of $ 20,000 , increasing to $ 25,000 in May 2024 and to $ 30,000 in May 2026, with a final balloon payment of $ 80,000 due on December 31, 2029. The note is secured by a stock pledge, described below, and at September 30, 2023, the total amount receivable on the note was $ 371,175 . In conjunction with the sale, we recognized a one-time gain of $ 1,148,225 .

In connection with the sale, the capital structure of Applied Nanotech was changed to give us, as the holder of Class B common stock of Applied Nanotech, a 30% economic interest, certain information rights, special consent rights, and tag-along rights, as well as the obligation to sell our stock under certain circumstances if other stockholders are selling. The Class A stock acquired by the buyers was pledged to secure the promissory note given in payment of the purchase price.

The following includes the detail of major classes of assets and liabilities of discontinued operations summarized on the accompanying unaudited consolidated financial statements:

The following is the detail of major line items that constitute income (loss) from discontinued operations:

SCHEDULE OF INCOME (LOSS) FROM DISCONTINUED OPERATIONS

		2023				2022
		For the Nine Months Ended
		September 30,
		2023				2022
Net Revenues		$	-			$	258,444
Cost of Sales			-				211,029
Gross Profit			-				47,415
Salaries, wages and related benefits			-				23,573
General and administrative expenses			-				21,961
Professional fees			-				-
Interest and other expense			-				581
Net income (loss) on discontinued operations		$	-			$	1,300

NOTE 3 – ACCOUNTS RECEIVABLE

At September 30, 2023 and December 31, 2022, accounts receivable consisted of the following:

SCHEDULE OF ACCOUNTS RECEIVABLE

		September 30, 2023				December 31, 2022
Accounts receivable		$	407,447			$	377,940
Less: allowance for doubtful accounts			( 85,867	)			( 29,375	)
Accounts receivable, net		$	321,580			$	348,565

NOTE 4 – INVENTORY

At September 30, 2023 and December 31, 2022, inventory consisted of the following:

SCHEDULE OF INVENTORY

		September 30, 2023				December 31, 2022
Raw materials		$	667,147			$	695,774
Work-in-progress			245,479				256,095
Finished goods			340,810				353,082
Inventory, gross			1,253,436				1,304,951
Less: reserve for obsolescence			( 260,719	)			( 184,878	)
Inventory, net		$	992,717			$	1,120,073

NOTE 5 – INVESTMENT IN SUBSIDIARY

The Company is accounting for its 30 % ownership interest in ANI by the equity method of accounting under which the Company’s share of the net income (loss) of ANI is recognized as income (loss) in the Company’s statement of operations. Any dividends received from ANI as well as periodic losses for the Company’s 30 % share will be treated as a reduction of the investment account. At September 30, 2023, the investment was $ 269,818 , included in non-current assets. For the three- and nine-month periods ended September 30, 2023, the Company recorded a loss from the investment in the subsidiary of $ 21,267 and income of $ 19,671 , respectively. For the three and nine-month periods ended September 30, 2022, the Company recorded income from the investment in subsidiary of $ 19,203 and $ 16,042 , respectively.

F- 7

NOTE 6 – NOTES PAYABLE AND FINANCE LEASES

Notes Payable

On January 7, 2022, the Company sold to one investor a $ 100,000 convertible note due March 31, 2025 . On January 26, 2022, and January 31, 2022, the Company sold two $ 50,000 convertible notes to two different investors. The two $ 50,000 notes are due March 31, 2026 . All three notes were issued at face value, and bear interest at 8 % per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $ 1.75 per share.

On July 27, 2022, the Company sold two convertible notes, one for $ 50,000 and one for $ 25,000 , both due on March 31, 2025 . On August 22, 2022, the Company sold a $ 25,000 convertible promissory note due March 31, 2026 . All three notes were issued at face value, and bear interest at 8 % per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $ 1.75 per share.

On October 26, 2022, the Company sold to an investor a $ 25,000 convertible promissory note due October 31, 2023 . Issued at face value, the note bears interest at 8 % per annum, payable semi-annually in cash. The note is convertible at any time at the option of the holder into shares of common stock at a conversion price of $ 1.75 per share. The note was subsequently extended to October 31, 2024.

On December 18, 2022, the Company issued a convertible promissory note for $ 50,000 that is secured by certain payroll tax credits the Company is entitled to receive under the Employee Retention Tax Credit program. The note was issued at face value and bears interest at 8 % per annum, payable at maturity which is eighteen months from date of issue. The note can be converted to common stock at any time at the option of the holders at a conversion price of $ 1.75 per share at which point accrued interest will be paid in cash.

On June 14, 2023, the Company issued a convertible, secured note and warrants to purchase 10,000 shares of the Company’s common stock for $ 50,000 with the same terms as the one issued on December 18, 2022. The warrants were recorded as a debt discount on the date of issuance for a total value of $ 5,333 .

On July 24, 2023, the Company issued at face value a convertible note in the original principal amount of $ 50,000 . The note is due two years from date of issue, bears interest at 8 % per annum and is convertible at $ 1.25 per share.

At September 30, 2023 and at December 31, 2022, we had outstanding convertible notes aggregating $ 470,716 and $ 375,000 in principal amount, net of unamortized debt discount of $ 4,284 and $ 0 , respectively. The convertible promissory notes have not been included in diluted earnings per share as they would be anti-dilutive.

On February 10, 2015, Nano Magic entered into a $ 373,000 promissory note (the “Equipment Note”) with KeyBank, N.A. (the “Bank”). The unpaid principal balance of this Equipment Note was payable in 60 equal monthly instalments payments of principal and interest through June 10, 2020 . The Equipment Note was secured by certain equipment, as defined in the Equipment Note, and bore interest computed at a rate of interest of 4.35 % per annum based on a year of 360 days. On June 18, 2019, Nano Magic entered into an Amendment to the Equipment Note with the Bank. By the amendment, the maturity date of the note was extended until April 10, 2022, the interest rate was raised to 6.29 % per year, and the monthly payments were reduced to $ 4,053 per month, including interest. On May 2, 2022, we amended the Equipment Note with Key Bank to extend the due date on the note until December 10, 2022. The interest rate remained the same at 6.29 % per year and the monthly payments remained at $ 4,053 per month. At September 30, 2023, the principal amount due under the Equipment Note had been paid in full. At December 31, 2022, $ 1,629 was outstanding under the Equipment Note.

Finance Leases

On August 11, 2020, the company entered into a finance lease for furniture. The Company financed $ 60,684 over a period of 36 months with monthly payments of $ 1,972 during that time. As of September 30, 2023, the lease was completely paid off.

On September 24, 2020, the company entered into a finance lease with Raymond Leasing Corporation for a forklift. Nano Magic LLC financed $ 14,250 . The lease term is 36 months with monthly payments of $ 425 . As of September 30, 2023, the lease was completely paid off.

In December 2020, the company entered into a finance lease for production equipment. The Company financed $ 85,000 over a period of 48 months with monthly payments of $ 2,135 during that time. As of September 30, 2023, the balance on the lease was $ 29,878 ; the current and non-current portions were $ 23,603 and $ 6,274 , respectively.

F- 8

NOTE 7 – RELATED PARTY TRANSACTIONS

At September 30, 2023 and at December 31, 2022, accounts payable – related parties totaled $ 92,958 and $ 87,119 , respectively, and is presented separately in current liabilities. These balances consist of amounts owed to directors and officers as well as to the landlord controlled by two of the Company’s directors.

Other compensation paid to directors was:

SCHEDULE OF RELATED PARTY TRANSACTIONS

		2023				2022				2023				2022
		Three Months ended September 30,								Nine Months ended September 30,
		2023				2022				2023				2022
Ronald J. Berman		$	-			$	30,000	+		$	-			$	114,150	+
Tom J. Berman		$	45,000	*		$	30,000	*		$	165,000	*		$	145,900	*
Other compensation		$	45,000	*		$	30,000	*		$	165,000	*		$	145,900	*

+	Legal and consulting fees.
*	Indicates gross amount accrued as salary. In an effort to save cash, the company is satisfying the accrued salary through a combination of cash and stock in each period.

At September 30, 2023 and at December 31, 2022, aggregate advances from Scott & Jeanne Rickert were $ 42,887 . On both those dates, accrued payroll for the Rickerts was an aggregate of $ 16,000 , which is included within accounts payable – related parties on the accompanying balance sheets.

We granted options to our President and CEO Tom Berman in lieu of salary: In April, an option to purchase up to 30,000 shares, fully vested for salary not paid from January to March, and, in May, a second option for up to 69,228 shares that vest at the rate of 7,692 shares monthly for salary not paid in April and subsequent months of 2023. Also in May, we granted our Chief Financial Officer an option for up to 100,000 shares in recognition of his services from 2019 through 2022. Both our CFO and our General Counsel were granted options in May for up to 60,000 shares, vesting 5,000 shares per month starting in January 2023 and each month thereafter. In May, 2023, we also granted director Ronald Berman an option to purchase up to 50,000 shares for services previously rendered and granted him an option for 45,000 shares that vest at the rate of 5,000 shares per month beginning in April and for each calendar month of 2023. All options have an exercise price of $ 0.65 per share and a four-year term.

One of the purchasers of the 70 % interest in Applied Nanotech in May, 2022, was Richard Fink who was one of our named executive officers until that sale.

Mr. Ron Berman and Mr. Tom Berman are the managers of the limited liability company that is the manager of PEN Comeback, LLC, PEN Comeback 2, LLC, Magic Growth, LLP, Magic Growth 2 LLC and Magic Growth 3 LLC. These five limited liability companies purchased shares of common stock and derivative securities from us in 2018, 2019, 2020, 2021 and 2022. See the subsection on Sales of Stock under Issuances of Common Stock in Note 8.

In addition, Mr. Tom Berman and Mr. Ron Berman are two of three individuals who share voting power of the sole manager of the limited liability company that is the Company’s landlord in Michigan. Together, Tom and Ron Berman hold, in the aggregate, a 5 % economic interest in the landlord entity. Another director, Miles Gatland, owns a 12.5 % interest in the Michigan landlord and he is a co-guarantor on the debt of that limited liability company. The lease for the Michigan facility gives us the right, during the first three years of the lease, to buy up to a 49% interest in the landlord for a price equal to 49% of the contributions received from other members. See Note 8, Stockholder’s Equity regarding the issuance of stock in partial satisfaction of unpaid rent. At September 30, 2023 and at December 31, 2022, rents accrued and unpaid totaled $ 71,958 and $ 57,119 , respectively.

NOTE 8 – STOCKHOLDERS’ EQUITY

Description of Preferred and Common Stock

Preferred Stock

The preferred stock may be issued in one or more series. The Company’s board of directors are authorized to issue the shares of preferred stock in such series and to fix from time to time before issuance thereof the number of shares to be included in any such series and the designation, powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, of such series.

Common Stock

The rights of each share of common are the same with respect to dividends, distributions and rights upon liquidation. Holders of common stock each have one vote per share in the election of directors and other matters submitted to a vote of the stockholders.

F- 9

Issuances of Common Stock

Common Stock Issued for Services

In February 2023, we reached an agreement with the landlord of our Michigan facility to accept 52,800 shares of our common stock at a price of $ 1.25 per share as partial payment of rent for the nine-month period from October 2022 through March 2023. Those shares were issued in March, 2023.

In May 2023, we reached a further agreement with the landlord that calls for us to pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $ 0.75 per share. We have the option to continue to use stock to pay a portion of the rent through 2024.

On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services. The shares are subject to forfeiture until vested. So long as the consulting services agreement remains in effect 4,273 shares vested in May for prior service, and another 4,273 shares vest at the end of May and each calendar month thereafter, with 4,277 shares vesting in December 2023. During 2024, 3,205 shares will vest at the end of each month, with 3,206 shares vesting at the end of December 2024.

In August the Company issued to each of three individuals who are serving on its advisory committee a total of 38,460 shares of restricted stock for their services during 2023. All shares vest ratably by December 31, 2023.

Sales of Common Stock and Derivative Equity Securities

During the quarter ended September 30, 2023, the Company sold an additional 533,331 shares of common stock for proceeds of $ 400,000 . In addition, during the three-month period, an investment made in April was cancelled and the $ 250,000 investment was reiussed at $ 0.75 per share, resulting in a net increase in the outstanding stock of 136,482 shares.

During the quarter ended September 30, 2022, the Company sold 283,334 shares of common stock for proceeds of $ 495,834 and warrants to purchase up to 283,310 shares of common stock for proceeds of $ 14,165 . The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $ 2.25 . During the nine-months ended September 30, 2022, the Company sold 727,780 shares of common stock for proceeds of $ 1,273,615 and warrants to purchase up to 727,700 shares of common stock for proceeds of $ 36,384 . The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $ 2.25 .

Stock Options

Stock options to purchase common stock outstanding at September 30, 2023 include those described below. No options were exercised during the period. No options have been included in diluted earnings per share as they would be anti-dilutive.

SCHEDULE OF STOCK OPTION PLAN ACTIVITY

		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding December 31, 2022			2,760,991			$	0.72				4.09			$	-
Exercised			-				-				-				-
Issued			636,909				0.65				3.65				155,406
Expired & forfeited			( 23,501	)			0.48				-				( 4,187	)
Outstanding September 30, 2023			3,374,399			$	0.71				3.40			$	636,951
Exercisable September 30, 2023			1,941,356			$	0.68				2.81			$	419,186

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS SHARE

		September 30, 2023				December 31, 2022
Stock options			3,374,399				2,760,991
Stock warrants			7,525,265				7,440,639
Total			10,899,664				10,201,630

F- 10

Warrants

During the three-month period ended September 30, 2023, no warrants were issued, but, in connection with the additional shares issued to the investor who bought shares and warrants in April 2023, the investor and the Company agreed to cancel the warrants to purchase 196,813 shares that had been issued to that investor in April. As of September 30, 2023, there were outstanding and exercisable warrants to purchase 7,525,265 shares of common stock. On May 26, 2022, the Board acted to extend the term of warrants that were issued in 2018, 2019, or the first quarter of 2020, adding an additional two years to the term of each of the 4,052,003 warrants issued in that period. The outstanding warrants have a weighted average exercise price of $ 1.72 per share and a weighted average remaining contractual term of 20.34 months. As of September 30, 2023, there was no intrinsic value for the warrants. No warrants have been included in diluted earnings per share as they would be anti-dilutive.

2021 Equity Incentive Plan

On March 2, 2021, our Board adopted the 2021 Nano Magic 2021 Equity Incentive Plan (the “Plan”) to allow equity compensation for those who provide services to the Company and to encourage ownership in the Company by personnel whose service to the Company is important to its continued progress, to encourage recipients to act as owners and thereby in the stockholders’ interest and to enable recipients to share in the Company’s success. Initially, 85,000 shares were available for issuance under the Plan and that number of options were also granted to employees on March 2, 2021. On April 8, 2021 the number of shares under the Plan was increased by 2,500 , and an additional 2,500 options were granted. On June 21, 2021 an additional 200,000 shares were made available for issuance under the Plan and options for 100,000 shares were granted, but subsequently forfeited. In February 2022, we granted 130,700 options with an exercise price of $ 0.80 and weighted average fair value on the grant date of $ 0.60 .

On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan. On May 30, 2023 the Board granted an additional 175,071 options under the 2021 Equity Plan to employees and a consultant. All options are at an exercise price of $ 0.65 .

Other Options

On April 12, 2023, the Company issued an additional 30,000 options to Tom J. Berman, our President. On May 30, 2023, the Board granted 384,228 options to officers and to a consultant who is also a director.

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Litigation

The Company may be, from time to time, subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. As of September 30, 2023 we were not a defendant in any proceedings. Our policy is to accrue costs for contingent liabilities, including legal proceedings or unasserted claims that may result in legal proceedings, when a liability is probable and the amount can be reasonably estimated. As of September 30, 2023, the Company has not accrued any amount for litigation contingencies.

NOTE 10 – SUBSEQUENT EVENTS

On October 16, 2023, the Company issued 52,800 shares of common stock to its landlord in Michigan in partial payment of rent.

On October 18, 2024, the Company and the holder of a convertible note dated October 26, 2022 in the original principal amount of $ 25,000 extended the maturity date of the note to October 31, 2024 . This note is included in long-term notes payable on the balance sheet as of September 31, 2023.

On October 16, and again on October 26, 2023, the Company sold 13,333 shares of common stock to an accredited investor for proceeds of $ 10,000 on each of those two dates.

On November 7, 2023, the Company sold 39,999 shares of common stock to an accredited investor for proceeds of $ 30,000 .

On November 9, 2023, the Company sold 266,667 shares of common stock to an accredited investor for proceeds of $ 200,000 .

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying unaudited condensed consolidated financial statements.

OVERVIEW

Nano Magic is a leader in developing and bringing to market cutting-edge nanotechnology-powered industrial and consumer cleaning, protection and anti-fog solutions formulated in Detroit, Michigan. Nano Magic focuses on innovative and advanced product solutions harnessing the magic power of nanotechnology to create a safer, more socially conscious, and higher performing world. Visit www.nanomagic.com for more information.

Effective May 31, 2022, we sold a majority interest in our subsidiary, Applied Nanotech, Inc. (“ANI”). ANI performs contract research services for the Company and for governmental and private customers and that work was previously reported as our Contract research segment. We retain a 30% interest in ANI that is now recorded as an equity investment.

RESULTS OF OPERATIONS

The following comparative analysis on results of operations was based primarily on the comparative condensed consolidated financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the unaudited condensed consolidated financial statements and the notes to those statements that are included elsewhere in this report. The results discussed below are for the three and nine months ended September 30, 2023 and 2022.

Comparison of Results of Continuing Operations for the Three and Nine Months ended September 30, 2023 and 2022

Revenues:

For the three and nine months ended September 30, 2023 and 2022, revenues from continuing operations were:

		Three Months Ended September 30,								Nine Months Ended September 30,
		2023				2022				2023				2022
Total revenue		$	658,159			$	807,026			$	2,064,481			$	1,819,951

For the three months ended September 30, 2023, revenues from continuing operations decreased by $148,867 or 18% as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023 revenues increased by $244,530 or 13%, as compared to the nine months ended September 30, 2022. The decrease experienced in 2023 was due to large e-commerce sales for the three-month period in 2022, and the increase for the nine-month period was due, primarily, to new retail programs.

Cost of sales

Cost of sales includes inventory costs, materials and supplies costs, internal labor and related benefits, subcontractor costs, depreciation, and allocated overheads and shipping and handling costs incurred.

		Three Months ended September 30,								Nine Months ended September 30,
		2023				2022				2023				2022
Cost of sales:		$	575,680			$	698,448			$	1,705,114			$	1,689,342

For the three months ended September 30, 2023, cost of revenues decreased by $122,768 or 18% as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, cost of revenues increased by $15,772 or 1% as compared to the nine months ended September 30, 2022. Cost of sales changed as a result of a favorable product mix change, and increased efficiency and cost cutting efforts over the last year, offset by an increase in the reserve for slow-moving inventory.

Gross profit

For the three months ended September 30, 2023, gross profit was $82,479 as compared to $108,578 for the prior year, a decrease of $26,099 or 24%. For the nine months ended September 30, 2023, gross profit was $359,367 as compared to $130,609 for the same period in the prior year, an increase of $228,758 or 175%. For the three-month period, the decrease was largely due to an increase in the reserve for slow-moving inventory. In the nine-month period, the increase was due to an emphasis on higher margin sales.

Other Operating Income

For the three and nine months ended September 30, 2023, other operating income amounted to $0 and $11,420 as compared to $95,701 for the three and nine months ended September 30, 2022. The difference is due to the recognition of one-time income booked for the settlement of claims.

Operating expenses

For the three months ended September 30, 2023, operating expenses decreased by $19,937 or 3% compared to the three months ended September 30, 2022. For the nine-month period ended September 20, 2023, operating expenses decreased by $297,433 or 11% as compared to the nine months ended September 30, 2022. For the three and nine months ended September 30, 2023 and 2022, operating expenses consisted of the following:

		Three Months Ended September 30,								Nine Months Ended September 30,
		2023				2022				2023				2022
Selling and marketing expenses		$	69,242			$	88,635			$	182,684			$	264,465
Salaries, wages and related benefits			233,701				308,745				702,263				1,021,463
Stock compensation expense			119,999				50,528				410,392				157,149
Research and development			24,375				4,566				36,650				15,266
Professional fees			78,080				129,362				380,301				572,135
General and administrative expenses			220,230				183,728				667,744				646,989
Total		$	745,627			$	765,564			$	2,380,034			$	2,677,467

●	For the three months ended September 30, 2023, selling and marketing expenses decreased by $19,393 or 22% as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, selling and marketing expenses decreased by $81,781 or 31% as compared to the nine months ended September 30, 2022. The decreases were due to reductions in marketing and advertising, attendance at fewer trade shows in 2023 and reduced costs for shows attended.
●	For the three months ended September 30, 2023, salaries, wages and related benefits decreased by $75,044 or 24%, as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, salaries, wages and related benefits decreased by $319,200 or 31%, as compared to the nine-months ended September 30, 2022. These decreases were due to reductions in headcount.
●	For the three months ended September 30, 2023, stock compensation expense increased by $69,471 or 137%. For the nine months ended September 30, 2023, stock compensation expense increased $253,243 or 161%. The increase was due in substantial part to the grant of options to employees in lieu of cash bonuses, payment of a portion of some salaries in options in lieu of cash, and other stock incentives to employees, consultants and advisors.
●	For the three months ended September 30, 2023, research and development costs increased by $19,809 or 434%, as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, research and development costs increased by $21,384 or 140%, as compared to the nine months ended September 30, 2022. The increase for the three-month period was due primarily to consulting costs and that was the largest component of the change for the nine-month period.
●	For the three months ended September 30, 2023, professional fees decreased by $51,282 or 40%, as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, professional fees decreased by $191,834 or 34%, as compared to the nine months ended September 30, 2022. The changes were due to a reduction in fees from professional services firms used by the Company, particularly reduced legal fees.
●	For the three months ended September 30, 2023, general and administrative expenses increased by $36,502 or 20% as compared to the three months ended September 30, 2022 due to an increase in bad debt expenses for the quarter. For the nine months ended September 30, 2023, general and administrative expenses increased by $20,755 or 3% as compared to the nine months ended September 30, 2022. The difference for the three-month period was due to timing, but the costs are essentially flat year to date.

Loss from operations

As a result of the factors described above, for the three months ended September 30, 2023, loss from operations amounted to $663,148 as compared to a loss of $561,285 for the three months ended September 30, 2022, an increase of $101,863 or 18%. For the nine months ended September 30, 2023, loss from operations amounted to $2,009,247 as compared to a loss of $2,451,157 for the nine months ended September 30, 2022, a reduction of $441,910 or 18%.

Income from investment in subsidiary

As a result of the sale of a 70% interest in ANI , we now report our 30% share of ANI’s income or loss as an investment in a subsidiary. For the three and nine months ended September 30, 2023 there was a loss of $21,267, and income of $19,671, respectively. For the three and nine-month periods ended September 30, 2022, we recorded income from that investment of $19,203 and $16,042, respectively.

Interest expense

For the three months ended September 30, 2023 interest expense was $12,068 as compared to $10,799 in the prior year, and for the nine months ended September 30, 2023 interest expense was $34,011 up from $26,414 in the prior year. The increases for the three- and nine-month comparative periods was due to accrued interest on convertible notes outstanding.

Other income (expense)

For the three months ended September 30, 2023, other expense was $3,192 as compared to income of $10,267 for the three months ended September 30, 2022. For the nine months ended September 30, 2023, other income was $20,010 as compared to $12,892 for the nine months ended September 30, 2022. The difference in the three-month period was due to a one-time tax expense and for the nine-month period due to increased interest accrued on the note receivable from ANI.

Loss from continuing operations

As a result of the foregoing, we reported a loss from continuing operations of $699,675 for the three-month period ended September 30, 2023 and a loss of $542,594 for the three-month period in the prior year, an increase of $157,081 or 29%. For the nine-month period ended September 30, 2023 our loss from continuing operations was $2,003,577 as compared to $2,448,637 for the nine-month period ended September 30, 2022, a reduction of $445,060 or 18%.

Income (loss) from discontinued operations

Effective May 31, 2022, we sold a 70% interest in our subsidiary ANI to two of its officers and long-time employees in exchange for a promissory note in the face amount of $450,000. On a continuing basis, we no longer recognize income from this operation in the statement of operations. For the nine months ended September 30, 2022, we recognized income of $1,300 and a one-time gain on the sale of discontinued operations of $1,148,225.

Net loss (income)

For the three months ended September 30, 2023, net loss was $699,675 as compared to a loss of $542,594 for the three months ended September 30, 2022. For the nine months ended September 30, 2023, net loss amounted to $2,003,577 as compared to a loss of $1,299,112 for the nine months ended September 30, 2022.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had working capital of $31,507 and $123,173 of unrestricted cash as of September 30, 2023 and working capital of $524,389 and $259,223 of unrestricted cash as of December 31, 2022.

The following table sets forth a summary of changes in our working capital from December 31, 2022 to September 30, 2023:

										December 31, 2022 to September 30, 2023
		September 30, 2023				December 31, 2022				Change in Working Capital				Percentage Change
Working capital:
Total current assets		$	1,572,117			$	1,900,858			$	(328,741	)			(17.29	)%
Total current liabilities			1,540,610				1,376,469				164,141				11.92	%
Working capital:		$	31,507			$	524,389			$	(492,882	)			(93.99	)%

The decrease in current assets was primarily due to a reduction in cash and in inventory. The increase in current liabilities was primarily due to an increase in accrued expenses.

Net cash used by operating activities was $(1,057,794) for the nine months ended September 30, 2023 as compared to net cash used by operating activities of $(1,561,063) for the nine months ended September 30, 2022, a net change of $503,269 or a reduction of 32%. Net cash used by operating activities for the nine months ended September 30, 2023 primarily resulted from net loss from continuing operations of $2,003,577 adjusted for add-backs of $697,590 and changes in operating assets and liabilities of $248,193.

Net cash provided by continuing investing activities was $10,648 for the nine months ended September 30, 2023, as compared to $20,090 for the same period in 2022. The change was due in substantial part to purchases of equipment and tooling as well as a reduction in proceeds from a note receivable.

Net cash provided by continuing financing activities was $911,096 for the nine months ended September 30, 2023 reflecting $950,332 in proceeds from sales of common stock, warrants and convertible notes, as compared to net cash provided by continuing financing activities of $1,484,785 for the same period in 2022. Net cash provided by discontinued financing activities was $0 and $20,000 for the nine months ended September 30, 2023 and September 30, 2022, respectively.

Future Liquidity and Capital Needs .

Our principal future uses of cash are for working capital requirements, including working capital to support increased product sales, sales and marketing expenses and reduction of accrued liabilities. Application of funds among these uses will depend on numerous factors including our sales and other revenues and our ability to control costs.

Equipment Financing and Loans

See note 6 to our unaudited condensed consolidated financial statements regarding our equipment loan and financing leases.

Off-Balance Sheet Arrangements

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as shareholder’s equity or that are not reflected in our consolidated unaudited financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

ITEM 3. Quantitative and Qualitative disclosures about market risk

Not applicable to smaller reporting companies.

ITEM 4. Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report (the “Evaluation Date”). Based upon this evaluation, our principal executive officer and principal financial officer concluded that we do not have sufficient resources in our accounting function to have segregation of duties so that the initiation of transactions, the custody of assets and the recording of transactions are performed by separate individuals. However, to the extent possible, these tasks are performed by separate individuals. Management evaluated our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

Changes in Internal Control

There were no changes identified in connection with our internal control over financial reporting during the three months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None

ITEM 1A. RISK FACTORS

Not required of smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan and an additional 30,000 in options to Tom J. Berman our President. The options were granted to individuals in lieu of cash for a portion of their salary for the period from December 31, 2022 through March 31, 2023. All options are at an exercise price of $0.65 per share for a four-year term and were fully vested on date of grant.

On April 14, 2023, the Company sold 196,851 shares of common stock to an accredited investor for proceeds of $246,064 and sold to that investor warrants to purchase up to 196,813 shares of common stock for proceeds of $3,936. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75.

On May 8, 2023, as part of a settlement agreement entered into on April 27, 2023, the Company sold to the counterparty 57,143 shares of common stock for proceeds of $100,000 at a price of $1.75 per share.

In March 2023, we issued 52,800 shares of common stock to our landlord in partial payment of our rent in Michigan.

On May 30, 2023 the Board granted 175,071 options under the 2021 Equity Plan to employees and consultants and an additional 399,228 options to officers and to a consultant who is also a director. All options are at an exercise price of $0.65 per share.

On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services.

On June 16, 2023, the Company issued a note at face value of $50,000 and sold that investor, for a price of $0.02 per warrant, warrants to purchase up to 10,000 shares of common stock at an exercise price of $1.75. On July 24, 2023, the Company sold a convertible note at its face amount of $50,000. On that same day, the Company sold 133,333 shares of common stock for proceeds of $100,000.

On July 24, 2023, the Company issued at face value a convertible note in the original principal amount of $50,000. The note is due two years from date of issue, bears interest at 8% per annum and is convertible at $1.25 per share.

On July 25, 2023, the Company issued 133,333 shares to an accredited investor at a price of $0.75 for proceeds of $100,000. In July and August 2023, the Company granted an aggregate of 192,302 shares of restricted stock to four individuals who will serve on the advisory committee. In August 2023, the Company issued 366,665 additional shares to accredited investors at a price of $0.75 per share for proceeds of $275,000. In September the Company issued 33,333 shares to another investor at that price for proceeds of $25,000. In addition, an investment made in April was cancelled and the $250,000 investment was reissued at $0.75 per share, resulting in a net increase in the outstanding stock of 136,482 shares.

On October 16, 2023, the Company issued 52,800 shares of common stock to its landlord in Michigan in partial payment of rent. On October 16, and again on October 26, 2023, the Company sold 13,333 shares of common stock to an accredited investor for proceeds of $10,000 on each of those two dates.

On November 7, 2023, the Company sold 39,999 shares of common stock to an accredited investor for proceeds of $30,000.

On November 9, 2023, the Company sold 266,667 shares of common stock to an accredited investor for proceeds of $200,000.

Grants under the 2021 Equity Plan were exempt under Rule 701. The sales and issuances of stock and other securities were exempt from registration under Section 4(a)(2) of the Securities Act. Cash proceeds were used for general corporate purposes.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit No.		Description
31.1*		Rule 13a-14(a)/15d-14(a) Certificate of Principal Executive Officer
31.2*		Rule 13a-14(a)/15d-14(a) Certificate of Chief Financial Officer
32.1*		Section 1350 Certificate of Principal Executive Officer and Chief Financial Officer
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema
101.CAL		Inline XBRL Taxonomy Extension Calculation
101.DEF		Inline XBRL Taxonomy Extension Definition
101.LAB		Inline XBRL Taxonomy Extension Labels
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)
*		Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

	Nano Magic Inc.
	(Registrant)
Date: November __, 2023	/s/ Tom J. Berman
	Tom J. Berman,
	President and Chief Executive Officer
Date: November __, 2023	/s/ Leandro Vera
	Leandro Vera
	Chief Financial Officer